LMAN2 and breast cancer: Survival analysis further revealed high LMAN2 expression as an indicator of poor prognosis in BC patients from multiple databases, including the TCGA‐BRCA (Figure 2B), Tang_2018 (Figure 2C), METABRIC (Figure 2D), and SCAN‐B databases (Figure 2E).